Showing results (571-580 of 609) with videos related to

Sort By:
Pageof 61
Biorxiv : the Preprint Server for Biology|March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Mabs|November 12, 2016
The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycanPing Tsui, Daniel R Higazi, Yanli Wu, et al.
Plos Neglected Tropical Diseases|December 19, 2024
Melioidosis in goats at a single Australian farm was caused by multiple diverse lineages of Burkholderia pseudomallei present in soilJoseph D Busch, Mirjam Kaestli, Mark Mayo, et al.
Science Advances|December 8, 2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivoJames A Torchia, Alexander H Tavares, Laura S Carstensen, et al.
Emerging Infectious Diseases|April 30, 2025
Postexposure Antimicrobial Drug Therapy in Goats Infected with Burkholderia pseudomalleiRichard A Bowen, Airn E Hartwig, Angela M Bosco-Lauth, et al.
Plos One|June 28, 2014
Host competence and helicase activity differences exhibited by West Nile viral variants expressing NS3-249 amino acid polymorphismsStanley A Langevin, Richard A Bowen, William K Reisen, et al.
Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
Bioconjugate Chemistry|September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition ChemistryMichael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
Vaccines|April 30, 2021
A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge ModelIzabela K Ragan, Lindsay M Hartson, Taru S Dutt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2025
An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunityWynton D McClary, Devin S Brandt, Madeleine F Jennewein, et al.
Pageof 61